Moscow-Sana
Today, the Russian Federal Biomedical Agency announced the creation of a method for treating acute respiratory syndrome caused by the Corona virus.
The treatment is based on "the use of artificial dextene hexa-peptide, which is an opioid receptor," a federal agency statement said.
According to the agency, the results of testing the substance on animals showed an increase in the survival rate, as between 70 and 100 percent of the animals whose material was inserted survived.
It is reported that "Dalargin" was registered in Russia earlier as a drug to treat venous ulcers and protect vital tissues and various organs.
